Lakefront Biotherapeutics SPON ADR

Lakefront Biotherapeutics SPON ADR is a security (CUSIP 36315X101) tracked across SEC portfolio filings. 90 institutional managers reported $911.5M on Form 13F as of 2026-06-30; 2 registered fund positions totaling $1.1M via N-PORT as of 2026-04-30.

Summary

Top institutional holders (Form 13F)

Showing 15 of 90 managers by value.

ManagerLocationValueShares
GILEAD SCIENCES, INC.FOSTER CITY, CA$500.2M16,707,477
TANG CAPITAL MANAGEMENT LLCSAN DIEGO, CA$113.6M3,785,991
Madison Avenue Partners, LPNEW YORK, NY$74.0M2,465,179
EcoR1 Capital, LLCSan Francisco, CA$50.0M1,667,119
Prosight Management, LPDALLAS, TX$46.5M1,550,000
DME Capital Management, LPNew York, NY$14.5M482,746
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$13.9M13,387
SEGALL BRYANT & HAMILL, LLCCHICAGO, IL$12.8M426,412
BlackRock, Inc.New York, NY$10.1M338,152
Point72 Asset Management, L.P.Stamford, CT$10.0M332,125
RENAISSANCE TECHNOLOGIES LLCNEW YORK, NY$9.5M315,400
D. E. Shaw & Co., Inc.New York, NY$6.5M215,718
UBS Group AGZurich, V8$5.3M175,289
CITADEL ADVISORS LLCMIAMI, FL$4.4M124,428
DAFNA Capital Management LLCLOS ANGELES, CA$3.9M130,175

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Steward Values Enhanced International FundSteward Funds Inc$875K28.99%
First Investors Hedged U.S. Equity Opportunities FundFIRST INVESTORS EQUITY FUNDS$230K18.57%

More